Initial Deployment Brings Omni One Systems to Sirica's First Bay Area Treatment Center

Collaboration Builds on Rutgers University Research and Advances Sirica's Plan to Establish 100 Autism Treatment Centers Nationwide

AUSTIN, Texas, July 07, 2026 (GLOBE NEWSWIRE) -- Virtuix Holdings Inc. (NASDAQ:VTIX), a leading developer of AI-driven, full-body simulation systems, today announced a strategic partnership with Sirica Therapeutics to deploy its Omni One platform for immersive autism therapy applications.

As part of the collaboration, Virtuix has sold and shipped the first two Omni One systems to Sirica's treatment center in the San Francisco Bay Area. The companies intend to use movement-centered virtual reality and AI-assisted therapeutic experiences to enhance engagement and treatment outcomes for children with autism and related disorders. Sirica has announced plans to establish approximately 100 Sirica Centers across the United States, creating a nationwide network of specialized autism treatment facilities.

The partnership represents another important milestone in Virtuix's expansion into healthcare applications following its recently announced research collaboration with Rutgers University to explore AI-assisted neurodivergent therapy using the Omni One platform and its collaboration with Florida Gulf Coast University using Omni One for neurological rehabilitation. These initiatives advance Virtuix’s strategy to extend its immersive simulation platform into clinical environments where movement-based technologies may enhance patient engagement and therapy efficacy.